Cardiovascular implication risks of Vioxx comparable to other NSAIDs.

Published: 2001-11-08 06:57:00

Updated: 2001-11-08 06:57:00

MSD's Vioxx, a COX-2 selective inhibitor NSAID, showed a comparable risk level in the cardiovascular side effects with other placebo and 4 NSAIDs according to the latest journal report of "Circulation".

The journal described a similar occurrence frequency of the above cardiovascular implications with Vioxx as compared to other NSAIDs (Ibuprofen, Diclofenac and Nabumeton) after surveying over...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.